What is the mechanism of action of GLP-1?

What is the mechanism of action of GLP-1?
Photo Credit: Pexels

GLP-1 medications, like Ozempic or Wegovy have taken over the food industry.

The potential for reducing food waste is high, as they can reduce the amount of food consumed. They could also reduce obesity by half, or even lead to an increased level of fortification. Researchers have even suggested that they may reduce alcohol consumption.

There may be much more than what these results suggest. They can also change our perception of food.

Does appetite suppression occur in the brain or in the body?

GLP-1 drugs suppress appetite, which means that they help users resist eating large quantities of food and certain kinds of foods.

Faris Zuraikat is an assistant professor of Columbia University. He says that this process involves both physiological and neurological processes, but the neural component has a greater importance.

He explains that GLP-1, a hormone produced by the body itself, is more effective than endogenous GLP-1.

He suggests that the drugs act on brain pathways related to reward, which could potentially change food preferences.

Phiala Moreing, director of sensory experience at MMR Research suggests that these drugs are more than appetite suppressors. These drugs may change the way we view food.

Zuraikat suggests that, while these drugs may cause some physical signs of satiety such as nausea or vomiting, their main effect is to “drive the neural control over food intake.”

What are the effects of GLP-1 on taste?

GLP-1 medications can also affect the way people taste. According to Zuraikat these changes are likely to include both baseline changes that affect all users and changes unique for each individual.

He suggests that GLP-1 receptors increase the user’s susceptibility to bitters and sweet tastes, but less so for salty ones.

Zuraikat suggests that research on food desirability or the “implicit desire” of people has revealed that the foods with higher energy density and fat content are the ones that they reject. It doesn’t appear to affect the consumption of sweets with low fat, despite the fact that the drug increases sensitivity.

There is no reduction in sweetness despite a slight increase in sensitivity. [of interest in] sweet foods.”

Mehring, from MMR Research says that sweetness is an innate taste. Even a foetus enjoys sweetness, according to research.

These changes in the way that people enjoy food could affect the foods they select.

I think that people will start to do a little more cost-benefit analysis in choosing what they eat, and how much.

Paulina Lang

Paulina Lan, the head of MMR Research’s behavioural sciences department, explains that “I believe people will start to do a little more cost-benefit analyses when choosing what they eat and how many calories to consume.”

They may, for example, feel better about themselves if they treat themselves occasionally, but they might not be able to eat. They may be “unable to do this because their body does not allow them to.”

The same approach applies to whether or not they decide to take the medication in the first instance. They will weigh the benefits of taking the medication – such as losing weight – against the costs – like not eating the foods they liked before – to decide if it’s worth it. “Is this something I am willing to give up?”

Foods can they play the same role in GLP-1 drug treatment?

In response to the popularity of GLP-1, some companies have developed foods that increase satiety the same way. These foods could fulfil the same function.

Lang, from MMR Research said: “I believe that many people would feel more comfortable if they didn’t have to depend on medications.” The problem, however, is that you’re bringing back the motivational aspect.

She says that the beauty of GLP-1 medications is that it removes the requirement for the consumer to be motivated in order to eat a particular way. This means that the person does not want to consume certain foods that are unhealthy. This aspect of food is brought back with the addition of satiety-engineered foods.

If you select the food which has a similar effect to that of your chosen food, then you must be consistent with that choice.

The food must be appealing and accessible.

Zuraikat, of Columbia University, explains that while a diet that promotes satiety can work, certain adaptations may offset this.

He says that there are both physiological and psychological factors to losing weight. These adaptations encourage eating energy-dense foods and increase motivation.

Zuraikat says that while GLP-1 is produced endogenously by foods, it isn’t as powerful as the GLP-1 produced by drugs.

The half-life of GLP-1 endogenous is only a few moments. “It’s not as potent a hormone that promotes satiety endogenously.”

Faris Zuraikat

The half-life of GLP-1 endogenous is only a few moments. This will not be as efficient as drugs. Endogenously, it’s not a very potent satiety-promoting hormone.

They’ve made the molecule with a longer half-life so it’s able to penetrate the brain better.

View Article Source

Share Article
Facebook
LinkedIn
X
Berkshire heating engineers put the boiler service first as January bill forecasts climb
As Christmas lists get shorter, Ascot home brand says one lasting piece beats five impulse buys
Ofcom names four age-check methods to underpin the under-16 social media ban
Secret Link